J Korean Soc Vasc Surg.  2004 May;20(1):70-77.

Cumulative Patency Rate of Percutaneous Transluminal Angioplasty and Stent Placement for Aortoiliac Occlusive Disease

• Choi DH
• Lee SM
• Koh SH
• Hong SW
• Oh SM
• Yoon C
• Park HC
• Oh JH

Abstract

PURPOSE
To evaluate the results of iliac artery angioplasty and stent placement as an option for the treatment of aortoiliac occlusive disease. METHOD: The records of 30 patients (mean age, 65.5 years) who underwent iliac artery angioplasty and/or stent placement were reviewed retrospectively. Presenting symptoms included asymptomatic (6.7%), claudication (73.3%), rest pain (10%), ulceration/tissue loss (3.3%), and blue toe syndrome (6.7%). Follow-up included angioplasty, Doppler ultrasound, and clinical examination. Mean follow-up time was 32 months. RESULT: Forty iliac lesions were treated. Thirty-seven percent of patients had hypertension, 33% had diabetes mellitus, 23% had coronary arterial disease, 6.6% had cerebrovascular disease, 3.3% had hyperlipidemia and 3.3% had renal insufficiency. TASC (Trans Atlantic Inter-Society Consensus) A, B, C and D disease types were 11 (36.7%) patients, 5 (16.7%), 10 (33.3%) and 4 (13.3%). Ipsilateral superficial femoral artery occlusion was present in 6 (20%) patients. Concomitant femoral artery bypass surgery was performed in 10 (33.3%) patients. The cumulative primary patency rates were 83.4%, 71.9% and 64.7% at 1, 2, and 3 years, respectively.
CONCLUSION
Iliac artery angioplasty and stent placement is a technically safe and effective treatment modality in patients without ipsilateral superficial femoral artery occlusion.

Keyword

Iliac artery; Angioplasty; Stent; Aortoiliac occlusive disease

MeSH Terms

Angioplasty*
Blue Toe Syndrome
Diabetes Mellitus
Femoral Artery
Follow-Up Studies
Humans
Hyperlipidemias
Hypertension
Iliac Artery
Renal Insufficiency
Retrospective Studies
Stents*
Ultrasonography